Delivery Order SPE2DB20D3104-SPE2DB24FV4Z2

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $4.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluorescein Sodium 10% vials in 5 ml sizes, with a total ceiling value of $7,138.82. The contract is a firm-fixed price delivery order contract with a period of performance ending on November 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorescein Sodium 10% vial (5 mL). The contract has a ceiling value of $5,432.72 and a period of performance extending through June 5, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,453.47 and an ultimate completion date of November 18, 2024. It is for the procurement of Fluorescite 10% vial, 5mL, a medical product used in ophthalmology. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5 ml vials of 10% Fluorescein Sodium. The contract is a firm fixed-price delivery order valued at $2,218.77, with a period of performance ending on March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorescite 10% vial, a specialty medication. The contract has a ceiling value of $3,939.18 and an ultimate completion date of October 23, 2024. The contract is a firm fixed-price vehicle, and no set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 5 mL vials of 10% Fluorescein Sodium, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,066.33, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 4, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluorescite 10% Vial 5ML, a pharmaceutical product, with a firm fixed price of $1,460.14 and a completion date of May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products and medical supplies. The contract has a ceiling value of $1,329.27 and a completion date of May 7, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. The contract covers a wide range of medical commodities, including specialty medications, brand-name and generic drugs,...
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB24FX4TW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorescein Sodium 10% Vial 5ml, a medical product, with a total ceiling value of $44,022.85. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is November 2, 2023....
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,057.25 and is a firm fixed-price delivery order with an ultimate completion date of April 28, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. The contract covers the delivery of a range of pharmaceutical products and medical...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV4Z2
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluorescein Sodium 10% Vial 5ML, a pharmaceutical product, with a ceiling value of $4,449.77 and a completion date of February 13, 2024.

The parent company, Cencora, Inc., doing business as Amerisourcebergen, holds a significant IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/14/25, 10:40 AM